BioCryst Pharmaceuticals (BCRX) Q4 2013 Results Results - Earnings Call Webcast

BioCryst Pharmaceuticals, Inc. (BCRX): Q4 EPS of -$0.09 in-line. Revenue of $10.6M (+158.5% Y/Y) beats by $1.79M.

The following audio is from a conference call that will begin on February 26, 2014 at 11:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.